天臣医疗
(688013)
| 流通市值：21.43亿 | | | 总市值：21.43亿 |
| 流通股本：8115.56万 | | | 总股本：8115.56万 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 55,677,592.99 | 326,733,883.44 | 243,831,328.07 | 156,168,251.45 |
| 营业总成本 | 52,954,345.86 | 243,879,907.75 | 170,220,030.83 | 107,096,608.2 |
| 其他经营收益 | | | | |
| 营业利润 | 9,612,138.98 | 95,612,202.6 | 79,477,357.32 | 53,144,769.68 |
| 利润总额 | 9,611,847.96 | 95,166,995.03 | 80,356,667.29 | 53,170,168.62 |
| 净利润 | 9,692,968.8 | 85,185,424.04 | 71,945,750.36 | 48,211,574.09 |
| 每股收益 | | | | |
| 其他综合收益 | 241,582.49 | -41,346.61 | -41,971.49 | -390,775.6 |
| 综合收益总额 | 9,934,551.29 | 85,144,077.43 | 71,903,778.87 | 47,820,798.49 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 367,589,071.24 | 376,920,852.71 | 424,660,812.32 | 394,514,199.84 |
| 非流动资产: | | | | |
| 非流动资产合计 | 326,795,414.35 | 296,007,540.47 | 251,360,457.93 | 246,302,778.17 |
| 资产总计 | 694,384,485.59 | 672,928,393.18 | 676,021,270.25 | 640,816,978.01 |
| 流动负债: | | | | |
| 流动负债合计 | 103,876,357.16 | 87,633,703.75 | 66,914,397.44 | 56,813,596.72 |
| 非流动负债: | | | | |
| 非流动负债合计 | 13,877,031.97 | 19,740,729.06 | 9,491,560.63 | 9,616,955.74 |
| 负债合计 | 117,753,389.13 | 107,374,432.81 | 76,405,958.07 | 66,430,552.46 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 576,631,096.46 | 565,553,960.37 | 599,615,312.18 | 574,386,425.55 |
| 股东权益合计 | 576,631,096.46 | 565,553,960.37 | 599,615,312.18 | 574,386,425.55 |
| 负债和股东权益合计 | 694,384,485.59 | 672,928,393.18 | 676,021,270.25 | 640,816,978.01 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 73,261,393.24 | 345,856,648.19 | 267,397,739.26 | 168,022,722.41 |
| 经营活动现金流出小计 | 75,176,920.83 | 273,870,434.78 | 203,613,579.4 | 131,044,440.54 |
| 经营活动产生的现金流量净额 | -1,915,527.59 | 71,986,213.41 | 63,784,159.86 | 36,978,281.87 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 237,216,694.33 | 553,499,166.8 | 451,698,978.28 | 437,602,582.75 |
| 投资活动现金流出小计 | 213,091,816.1 | 535,975,645.25 | 453,013,413.25 | 396,778,976.76 |
| 投资活动产生的现金流量净额 | 24,124,878.23 | 17,523,521.55 | -1,314,434.97 | 40,823,605.99 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 48,895,800 | 103,107,978.92 | 69,737,978.92 | 55,687,978.92 |
| 筹资活动现金流出小计 | 24,298,125.75 | 163,807,988.24 | 108,874,588.09 | 105,593,343.03 |
| 筹资活动产生的现金流量净额 | 24,597,674.25 | -60,700,009.32 | -39,136,609.17 | -49,905,364.11 |
| 汇率变动对现金及现金等价物的影响 | -261,864.59 | 5,844,853.06 | 7,266,846.55 | 6,642,598.5 |
| 现金及现金等价物净增加额 | 46,545,160.3 | 34,654,578.7 | 30,599,962.27 | 34,539,122.25 |
| 期末现金及现金等价物余额 | 169,386,123.76 | 98,780,466.28 | 94,725,849.85 | 98,665,009.83 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 34,654,578.7 | - | 34,539,122.25 |